Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease

Anushka Patel1, Mark Woodward, Duncan J Campbell

  • 1The George Institute for International Health, University of Sydney, PO Box M201, Missenden Road, Sydney, NSW 2050, Australia. apatel@thegeorgeinstitute.org

Insights

Plasma lipids like cholesterol and triglycerides do not predict recurrent stroke in patients with cerebrovascular disease. However, lipid levels are linked to myocardial infarction (MI) risk.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Clinical Research

Background:

  • Established cerebrovascular disease increases the risk of recurrent vascular events.
  • Plasma lipids are key modifiable risk factors for cardiovascular disease.
  • The specific role of lipids in recurrent stroke versus other vascular events requires further elucidation.

Purpose of the Study:

  • To investigate the association between plasma lipid levels (total cholesterol, HDL cholesterol, triglycerides) and the risk of recurrent vascular events.
  • To differentiate the impact of lipids on stroke subtypes (hemorrhagic, ischemic) versus other major adverse cardiovascular events (myocardial infarction, heart failure).

Main Methods:

  • Nested case-control studies within the Perindopril Protection Against Recurrent Stroke (PROGRESS) trial.
  • Analysis of baseline plasma lipid profiles in 895 patients with established cerebrovascular disease.
  • Statistical adjustment for major cardiovascular risk factors.

Main Results:

  • No significant association was found between plasma lipid variables and the risk of hemorrhagic or ischemic stroke.
  • Total cholesterol was positively associated with myocardial infarction (MI) risk (OR 2.00).
  • HDL cholesterol was inversely associated with MI risk (OR 0.58) and showed a borderline inverse association with heart failure risk (P=0.05).

Conclusions:

  • Plasma lipid levels are not predictive of recurrent stroke in individuals with established cerebrovascular disease.
  • Lipid profiles, particularly total cholesterol and HDL cholesterol, are significantly associated with the risk of myocardial infarction in this patient population.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
769
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
859
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
976
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
53